Prescription Drugs Market - Global Professional Analysis and Forecast to 2026

Oct 13, 2019 | 194 PAGES | REPORT CODE: CMM208578

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

The worldwide Prescription Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.3% during the forecast period.

This report presents the market size and development trends by detailing the Prescription Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Prescription Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Prescription Drugs industry and will help you to build a panoramic view of the industrial development.

Prescription Drugs Market, By Type:

Brand Drugs
Generic Drug

Prescription Drugs Market, By Application:

Hospital
Clinic
Other

Some of the leading players are as follows:

Shire
Merck & Co. (MSD)
GlaxoSmithKline (GSK)
Eli Lilly
Bristol-Myers Squibb
AbbVie
Boehringer Ingelheim
Gilead Sciences
Sanofi
Novo Nordisk
Takeda
Amgen
Johnson & Johnson
Bayer
Novartis
AstraZeneca
Allergan
Teva
Roche
Pfizer

Geographically, Major regions are analyzed in details are as follows:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Table of Contents

1 Methodology and Scope

1.1 Market Segmentation & Scope

1.1.1 Technology Type
1.1.2 Product
1.1.3 Application
1.1.4 Regional scope
1.1.5 Estimates and forecast timeline

1.2 Research Methodology
1.3 Information Procurement

1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research

1.4 Information or Data Analysis

1.4.1 Data analysis models

1.5 Market Formulation & Validation
1.6 Model Details

1.6.1 Commodity flow analysis
1.6.2 Volume price analysis

1.7 List of Secondary Sources
1.8 List of Abbreviations

2 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook

3 Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
3.1.1 Parent market outlook

3.1.2 Ancillary market outlook

3.2 Market Segmentation

3.2.1 Analysis

3.3 Market Dynamics

3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3 Industry opportunities

3.4 Penetration & Growth Prospect Mapping

3.4.1 Penetration & growth prospect mapping analysis

3.5 Business Environment Analysis Tools

3.5.1 Porter's five forces analysis
3.5.2 PESTLE analysis
3.5.3 Major deals & strategic alliances analysis

4 Prescription Drugs Market: Technology Type Analysis

4.1 Prescription Drugs Technology Type Market Share Analysis, 2018 & 2026
4.2 Prescription Drugs Technology Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

4.3.1 Brand Drugs
4.3.2 Generic Drug

5 Prescription Drugs Market: Product Analysis

5.1 Prescription Drugs Product Market Share Analysis, 2018 & 2026
5.2 Prescription Drugs Product Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Prescription Drugs Market: Application Analysis

6.1 Prescription Drugs Application Market Share Analysis, 2018 & 2026
6.2 Prescription Drugs Application Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

6.3.1 Hospital
6.3.2 Clinic
6.3.3 Other

7 Prescription Drugs Market: Regional Analysis

7.1 Prescription Drugs Regional Market Share Analysis, 2018 & 2026
7.2 Prescription Drugs Regional Market: Segment Dashboard
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
7.4 List of Players at Regional Level

7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific

7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA

7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

7.6.1 North America
7.6.2 Europe
7.6.3 Asia Pacific
7.6.4 Latin America
7.6.5 Middle East & Africa

8 Competitive Analysis

8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3 Vendor Landscape

8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

9.1 Shire

9.1.1 Shire Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis

9.2 Merck & Co. (MSD)

9.2.1 Merck & Co. (MSD) Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis

9.3 GlaxoSmithKline (GSK)

9.3.1 GlaxoSmithKline (GSK) Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis

9.4 Eli Lilly

9.4.1 Eli Lilly Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis

9.5 Bristol-Myers Squibb

9.5.1 Bristol-Myers Squibb Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis

9.6 AbbVie

9.6.1 AbbVie Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis

9.7 Boehringer Ingelheim

9.7.1 Boehringer Ingelheim Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis

9.8 Gilead Sciences

9.8.1 Gilead Sciences Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis

9.9 Sanofi

9.9.1 Sanofi Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis

9.10 Novo Nordisk

9.10.1 Novo Nordisk Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis

9.11 Takeda

9.11.1 Takeda Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis

9.12 Amgen

9.12.1 Amgen Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis

9.13 Johnson & Johnson

9.13.1 Johnson & Johnson Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis

9.14 Bayer

9.14.1 Bayer Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis

9.15 Novartis

9.15.1 Novartis Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis

9.16 AstraZeneca

9.16.1 AstraZeneca Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis

9.17 Allergan

9.17.1 Allergan Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis

9.18 Teva

9.18.1 Teva Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis

9.19 Roche

9.19.1 Roche Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis

9.20 Pfizer

9.20.1 Pfizer Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis

The List of Tables and Figures (Totals 80 Figures and 162 Tables)

Figure Brand Drugs Prescription Drugs market, 2015 - 2026 (USD Million)
Figure Generic Drug Prescription Drugs market, 2015 - 2026 (USD Million)
Figure Hospital market, 2015 - 2026 (USD Million)
Figure Clinic market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
Table List of players in North America
Table List of players in Europe
Table List of players in Asia Pacific
Table SWOT analysis
Table North America Prescription Drugs market, by country, 2015 - 2026 (USD Million)
Table North America Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table North America Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table North America Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.S. Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table U.S. Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table U.S. Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Canada Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Canada Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Canada Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Europe Prescription Drugs market, by country, 2015 - 2026 (USD Million)
Table Europe Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Europe Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Europe Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.K. Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table U.K. Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table U.K. Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Germany Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Germany Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Germany Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table France Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table France Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table France Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Italy Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Italy Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Italy Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Spain Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Spain Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Spain Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Asia Pacific Prescription Drugs market, by country, 2015 - 2026 (USD Million)
Table Asia Pacific Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Asia Pacific Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Asia Pacific Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table China Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table China Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table China Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Japan Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Japan Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Japan Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table India Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table India Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table India Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Latin America Prescription Drugs market, by country, 2015 - 2026 (USD Million)
Table Latin America Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Latin America Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Latin America Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Brazil Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Brazil Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Brazil Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Mexico Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Mexico Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Mexico Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Argentina Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Argentina Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Argentina Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table MEA Prescription Drugs market, by country, 2015 - 2026 (USD Million)
Table MEA Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table MEA Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table MEA Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table South Africa Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table South Africa Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table South Africa Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Nigeria Prescription Drugs market, by type, 2015 - 2026 (USD Million)
Table Nigeria Prescription Drugs market, by product, 2015 - 2026 (USD Million)
Table Nigeria Prescription Drugs market, by application, 2015 - 2026 (USD Million)
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Company market position analysis
Table Company Profiles
Table Shire Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co. (MSD) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline (GSK) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AbbVie Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Gilead Sciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amgen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis

REPORTS

Let’s Pullulate and Expand Your Business

Prescription Drugs Market - Global Professional Analysis and Forecast to 2026

Report Purchase